Go Digit’s ₹30 crore investment in Dr Reddy’s highlights its growing interest in pharma. India's pharma sector is projected to reach $130 billion by 2030, with Dr. Reddy’s leading in generics and biosimilars. As healthcare and insurance converge, this move signals a trend of insurers diversifying into medical ecosystems for long-term strategic growth.